On Monday, Procept BioRobotics Corp (NASDAQ: PRCT) was -4.66% drop from the session before settling in for the closing price of $41.23. A 52-week range for PRCT has been $37.12 – $103.81.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -12.56% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 15.14%. With a float of $52.83 million, this company’s outstanding shares have now reached $55.58 million.
In an organization with 756 employees, it is important to assess its efficiency.
Procept BioRobotics Corp (PRCT) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Procept BioRobotics Corp stocks. The insider ownership of Procept BioRobotics Corp is 5.04%, while institutional ownership is 96.28%. The most recent insider transaction that took place on Aug 13 ’25, was worth 785,138. In this transaction Director of this company bought 20,000 shares at a rate of $39.26, taking the stock ownership to the 863,159 shares. Before that another transaction happened on Jun 10 ’25, when Company’s Director sold 25,000 for $63.91, making the entire transaction worth $1,597,711. This insider now owns 64,363 shares in total.
Procept BioRobotics Corp (PRCT) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.4 earnings per share (EPS) during the time that was better than consensus figure (set at -0.49) by 0.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 36.69% during the next five years compared to -12.56% drop over the previous five years of trading.
Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators
You can see what Procept BioRobotics Corp (PRCT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.86. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.56, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -0.98 in one year’s time.
Technical Analysis of Procept BioRobotics Corp (PRCT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.82 million. That was inferior than the volume of 1.02 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 42.33%.
During the past 100 days, Procept BioRobotics Corp’s (PRCT) raw stochastic average was set at 7.37%, which indicates a significant decrease from 20.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.19 in the past 14 days, which was lower than the 2.72 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $52.20, while its 200-day Moving Average is $65.58. However, in the short run, Procept BioRobotics Corp’s stock first resistance to watch stands at $40.63. Second resistance stands at $41.96. The third major resistance level sits at $42.66. If the price goes on to break the first support level at $38.60, it is likely to go to the next support level at $37.90. Assuming the price breaks the second support level, the third support level stands at $36.57.
Procept BioRobotics Corp (NASDAQ: PRCT) Key Stats
There are 55,636K outstanding shares of the company, which has a market capitalization of 2.19 billion. As of now, sales total 224,500 K while income totals -91,410 K. Its latest quarter income was 79,180 K while its last quarter net income were -19,580 K.
